Literature DB >> 32542994

Association of Perfusion Characteristics and Posttransplant Liver Function in Ischemia-Free Liver Transplantation.

Zhiheng Zhang1,2,3, Yunhua Tang1,2,3, Qiang Zhao1,2,3, Linhe Wang1,2,3, Caihui Zhu1,2,3, Weiqiang Ju1,2,3, Dongping Wang1,2,3, Lu Yang4, Linwei Wu1,2,3, Maogen Chen1,2,3, Shanzhou Huang1,2,3, Ningxin Gao1,2,3, Zebin Zhu1,2,3, Yixi Zhang1,2,3, Chengjun Sun1,2,3, Wei Xiong4, Yuekun Shen4, Yi Ma1,2,3, Anbin Hu1,2,3, Xiaofeng Zhu1,2,3, Jian Rong5, Changjie Cai6, Zhiyong Guo1,2,3, Xiaoshun He1,2,3.   

Abstract

It has been shown that normothermic machine perfusion (NMP), a novel preservation method, is able to assess and resuscitate liver grafts with risk factors. However, there is no consistent criteria for the assessment of liver grafts with NMP. Ischemia-free liver transplantation (IFLT) includes innovative surgical techniques and NMP, which can protect liver grafts from ischemia throughout organ procurement, preservation, and implantation. In our center, 28 human livers from donation after brain death donors were subjected to IFLT between July 2017 and October 2018. The correlation between posttransplant liver function tests with the perfusion parameters, blood gas analysis of perfusate, and bile biochemistry were analyzed. During the preservation phase, the vascular flow was stable, and the lactate level decreased rapidly. The transaminase release in the perfusate was low but stable, whereas the glucose level remained high. The perfusate lactate and aspartate aminotransferase (AST) levels at 1 hour of perfusion were correlated with the posttransplant peak AST level. There were negative correlations between the portal vein and hepatic artery flows at the end of perfusion and the peak transaminase levels within 7 days after transplantation. In conclusion, during IFLT, NMP is able to bridge the liver grafts from donors to recipients and can allow the assessment of liver function by perfusion characteristics.
Copyright © 2020 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2020        PMID: 32542994     DOI: 10.1002/lt.25825

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  4 in total

1.  Viability testing of discarded livers with normothermic machine perfusion: Alleviating the organ shortage outweighs the cost.

Authors:  Siavash Raigani; Reinier J De Vries; Cailah Carroll; Ya-Wen Chen; David C Chang; Stuti G Shroff; Korkut Uygun; Heidi Yeh
Journal:  Clin Transplant       Date:  2020-09-23       Impact factor: 2.863

2.  En bloc procurement of porcine abdominal multiple organ block for ex situ normothermic machine perfusion: a technique for avoiding initial cold preservation.

Authors:  Chuanbao Chen; Maogen Chen; Xiaohong Lin; Yiwen Guo; Yihao Ma; Zhitao Chen; Weiqiang Ju; Xiaoshun He
Journal:  Ann Transl Med       Date:  2021-07

3.  Ischemic-Free Liver Transplantation Reduces the Recurrence of Hepatocellular Carcinoma After Liver Transplantation.

Authors:  Yunhua Tang; Tielong Wang; Weiqiang Ju; Fangcong Li; Qi Zhang; Zhitao Chen; Jinlong Gong; Qiang Zhao; Dongping Wang; Maogen Chen; Zhiyong Guo; Xiaoshun He
Journal:  Front Oncol       Date:  2021-12-13       Impact factor: 6.244

4.  Abrogation of graft ischemia-reperfusion injury in ischemia-free liver transplantation.

Authors:  Zhiyong Guo; Jinghong Xu; Shanzhou Huang; Meixian Yin; Qiang Zhao; Weiqiang Ju; Dongping Wang; Ningxin Gao; Changjun Huang; Lu Yang; Maogen Chen; Zhiheng Zhang; Zebin Zhu; Linhe Wang; Caihui Zhu; Yixi Zhang; Yunhua Tang; Haitian Chen; Kunpeng Liu; Yuting Lu; Yi Ma; Anbin Hu; Yinghua Chen; Xiaofeng Zhu; Xiaoshun He
Journal:  Clin Transl Med       Date:  2022-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.